Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
11.25
+0.79 (7.55%)
Sep 29, 2026, 9:55 AM EDT - Market open
Ginkgo Bioworks Holdings Revenue
Ginkgo Bioworks Holdings had revenue of $20.16M in the quarter ending June 30, 2026, a decrease of -48.49%. This brings the company's revenue in the last twelve months to $111.86M, down -51.54% year-over-year. In the year 2025, Ginkgo Bioworks Holdings had annual revenue of $170.16M, down -25.06%.
Revenue (ttm)
$111.86M
Revenue Growth
-51.54%
P/S Ratio
5.32
Revenue / Employee
$273,033
Employees
485
Market Cap
757.58M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 170.16M | -56.89M | -25.06% |
| Dec 31, 2024 | 227.04M | -24.41M | -9.71% |
| Dec 31, 2023 | 251.46M | -226.25M | -47.36% |
| Dec 31, 2022 | 477.71M | 163.87M | 52.21% |
| Dec 31, 2021 | 313.84M | 237.18M | 309.40% |
| Dec 31, 2020 | 76.66M | 22.47M | 41.48% |
| Dec 31, 2019 | 54.18M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Pharming Group | 366.48M |
| MiMedx Group | 355.17M |
| Verastem | 87.53M |
| Wave Life Sciences | 65.37M |
| Aclaris Therapeutics | 8.22M |
| DBV Technologies | 5.04M |
| Silence Therapeutics | 615.00K |
DNA News
- 1 hour ago - Ginkgo Bioworks, Apheris announce kick off of Antibody Developability Consortium - TheFly
- 13 days ago - Ginkgo Bioworks announces partnership with Lilly TuneLab - TheFly
- 13 days ago - Ginkgo Datapoints Announces Partnership with TuneLab to Close the Gap between AI Models and Lab Data - Business Wire
- 19 days ago - Ginkgo Bioworks awarded up to $17.5M subcontract under ARPA-H GIVE program - TheFly
- 19 days ago - Ginkgo Bioworks Joins ARPA-H GIVE Program to Build Autonomous Manufacturing System for Individualized RNA Medicines - Business Wire
- 7 weeks ago - Ginkgo Bioworks downgraded to Hold from Buy at TD Cowen - TheFly
- 7 weeks ago - Ginkgo Bioworks Holdings Earnings Call Transcript: Q2 2026 - Transcripts
- 7 weeks ago - Ginkgo Bioworks Holdings Earnings release: Q2 2026 - Filings